4.3 Acute Liver Failure, Cirrhosis, Ascites, and Jaundice Evaluation
Key Takeaways
Acute liver injury with coagulopathy and new hepatic encephalopathy usually without established cirrhosis requires urgent liver-unit discussion. Use the jaundice-to-encephalopathy interval for the named O’Grady subtypes.
Give NAC for paracetamol toxicity according to exposure and timing. The King’s College criteria support urgent transplant assessment and are one part of specialist selection.
Perform early paracentesis for new or admitted cirrhotic ascites. SAAG ≥11 g/L supports portal hypertension. At ≥250 neutrophils per microlitre, treat suspected SBP promptly and assess for another source. Give albumin when indicated, including with rising creatinine, after assessing volume status.
Use current HRS-AKI criteria and selective volume resuscitation. For overt hepatic encephalopathy in cirrhosis, treat precipitants, consider lactulose and assess the need for secondary prevention.
Interpret transferrin saturation and ferritin together in suspected iron overload. The HFE genotype and fibrosis stage guide the next decisions.
Recognise Acute Liver Failure
Acute liver failure (ALF) combines acute liver injury, impaired clotting from hepatic dysfunction (typically an INR around or above 1.5) and new hepatic encephalopathy, usually without pre-existing cirrhosis. A very high aminotransferase or bilirubin level is not required. Think of severe acute liver injury when INR rises before encephalopathy develops, and discuss worsening cases early. Check for pre-existing disease. Wilson disease and autoimmune hepatitis can present with the ALF phenotype despite previously unrecognised liver disease. An acute deterioration with organ failure in established advanced disease is a different syndrome.
Under the original O'Grady classification, the interval is measured from jaundice to encephalopathy: hyperacute within 7 days, acute at 8–28 days, and subacute during weeks 5–12. Hyperacute presentations include paracetamol toxicity and ischaemic injury. They can have marked aminotransferase elevation and a substantial risk of cerebral oedema. Later presentations can include idiosyncratic drug-induced or indeterminate injury. Prognosis depends on the cause, encephalopathy and organ dysfunction. Timing does not justify delaying referral.
In a patient with altered mental state and possible acute liver failure, assess ABCDE and glucose, seek critical care and contact the liver team promptly. Check serial INR, blood gas, glucose, lactate, renal function and neurological status. Review prescription and non-prescription drugs, toxins, circulation, pregnancy if relevant, and causes such as viral or autoimmune hepatitis. Severe encephalopathy can compromise the airway. St Vincent's University Hospital hosts Ireland's National Liver Transplant Unit.
Recognise paracetamol-related acute liver failure
An overdose can deplete glutathione and allow the reactive metabolite NAPQI to injure centrilobular hepatocytes. Give N-acetylcysteine (NAC) according to local toxicology guidance. For known single acute ingestions, use the Irish treatment line from 100 mg/L at four hours to 15 mg/L at 15 hours. Start NAC without waiting for a delayed level after a potentially toxic exposure when the result will be too late for treatment by eight hours. The timed nomogram is unsuitable for staggered or uncertain-time overdose. Use the protocol-specific initial course and end-of-course assessment. Continue NAC and seek advice for ongoing toxicity or liver injury. Give it promptly after a staggered overdose or when overdose timing is uncertain. See the guide's toxicology section for the labelled three-bag and Cork SNAP regimens.
Transplant assessment
Discuss severe or worsening acute liver injury with a liver unit promptly. The King's College criteria support prognosis and urgent specialist transplant assessment. They do not make the listing decision by themselves.
- Paracetamol acute liver failure: arterial pH below 7.30 after adequate fluid resuscitation, or all of grade III/IV hepatic encephalopathy, creatinine above 300 micromol/L and INR above 6.5. Arterial lactate after resuscitation can add prognostic information.
- Non-paracetamol acute liver failure: INR above 6.5, or at least three of the original risk features. These are age under 10 or over 40, an unfavourable aetiology such as an indeterminate or idiosyncratic drug cause, jaundice for more than seven days before encephalopathy, bilirubin above 300 micromol/L and INR above 3.5.
HPRA Parvolex SmPC · EASL acute liver failure guidance · King's College prognostic study · Arterial lactate study
Cirrhosis, Portal Hypertension and Ascites
Fibrosis and nodular remodelling increase intrahepatic resistance. Portal hypertension and splanchnic vasodilatation reduce effective arterial filling, increasing renal sodium and water retention and contributing to ascites. Variceal bleeding, clinically evident ascites and overt hepatic encephalopathy are important manifestations of decompensation. A compensated patient can still have significant portal hypertension. Assess cause and stage and look for sarcopenia, thrombocytopenia, splenomegaly or abdominal wall collaterals. Consider alcohol, chronic viral infection and metabolic dysfunction-associated steatotic liver disease (MASLD), among other causes. In at-risk adults with MASLD, EASL supports sequential use of a blood-based fibrosis score such as FIB-4 followed by elastography when indicated. Steatosis alone does not establish cirrhosis.
Hepatology follow-up includes treatment of the cause, nutrition and appropriate assessment for variceal risk. In selected patients with clinically significant portal hypertension, a non-selective beta blocker such as carvedilol can reduce the risk of decompensation when tolerated. Use haemodynamics, renal status and the hepatology plan to guide preventive treatment. Suspected acute variceal bleeding requires urgent resuscitation, vasoactive therapy and antibiotics under the local pathway, plus endoscopic assessment as described in the GI bleeding section. EASL recommends ultrasound surveillance at 6-month intervals for eligible people with cirrhosis who could benefit from HCC treatment.
Ascites Assessment and Management
Arrange early diagnostic paracentesis for new ascites and for admitted patients with cirrhosis and ascites, especially with infection, gastrointestinal bleeding, worsening renal function or encephalopathy. Send an ascitic cell count and differential, protein and albumin. When infection is suspected, inoculate ascitic fluid into blood culture bottles at the bedside. Request cytology, amylase or other studies when the suspected cause warrants them.
The serum–ascites albumin gradient (SAAG) is serum albumin minus ascitic albumin, using paired samples and the same units. A gradient ≥11 g/L supports portal hypertension. Low ascitic total protein in this setting usually fits cirrhosis. With a high gradient plus total protein ≥25 g/L, consider a cardiac cause, among other possibilities. With SAAG <11 g/L consider peritoneal malignancy, tuberculosis, pancreatic ascites and other causes according to the clinical setting. The gradient informs probability and can be misleading in an individual patient.
For uncomplicated cirrhotic ascites, consider dietary sodium advice and individualised diuretics, monitoring weight, sodium, potassium and creatinine. Tense or refractory ascites can require therapeutic drainage. BSG guidance recommends albumin 8 g for each litre removed when more than 5 L is drained to reduce circulatory dysfunction. Recurrent ascites despite appropriate management should prompt specialist review for transjugular intrahepatic portosystemic shunt (TIPS) or transplant suitability.
Identify undernutrition despite fluid-related weight gain
Ask about intake, early satiety, unplanned loss before fluid accumulated and declining strength. Ascites and oedema raise scale weight and can hide loss of muscle or fat. Use an appropriate nutrition risk tool, clinical assessment and dietetic support. In stable cirrhosis with low intake, offer smaller, more frequent meals and a late-evening snack, and consider oral supplements when food alone is insufficient. Use an individual protein and energy plan rather than routine protein restriction in encephalopathy. Review nutrition alongside diuretic treatment and after drainage. Anyone with prolonged negligible intake and risk of refeeding complications needs electrolyte and vitamin assessment and a monitored feeding plan.
ESPEN practical guideline on clinical nutrition in liver disease · ACG liver nutrition guideline.
Detecting and Treating Ascitic Infection
In a patient with cirrhotic ascites, ≥250 neutrophils per microlitre establishes ascitic neutrophilia requiring prompt empirical treatment for spontaneous bacterial peritonitis (SBP) when there is no evident surgically treatable source. This threshold is 0.25 × 10⁹/L. To calculate the count, multiply total white cells by the neutrophil fraction. A negative culture does not rule out clinically important infection at this count. For a bloody specimen, discuss correction with the laboratory when interpretation would change management.
Suspect secondary peritonitis when there are focal signs, an unusually high ascitic neutrophil count, several organisms on culture, or an inadequate clinical response. Low ascitic glucose and high total protein or LDH can support concern. Fluid findings alone cannot rule a surgical source in or out. If suspected, arrange urgent imaging and surgical review alongside resuscitation and antibiotics.
Start empiric IV antibiotics promptly. Choose them with the local guideline based on community versus hospital acquisition, severity, prior resistant organisms and allergies. A third-generation cephalosporin is an example when appropriate for community-acquired disease with low resistance risk. Adjust treatment using cultures and clinical response. Consider repeating the tap if response is inadequate or secondary peritonitis is suspected.
Assess creatinine and volume status when deciding on albumin. For SBP with renal dysfunction or rising creatinine, BSG recommends IV albumin 1.5 g/kg within 6 hours and 1 g/kg on day 3. Look for overload and use senior or hepatology guidance. The Sort trial supports the benefit of adding albumin to antibiotics in cirrhosis with SBP. After recovery, discuss secondary antibiotic prophylaxis and transplant suitability with hepatology. Select the regimen and review duration with the specialist and local antimicrobial guidance.
Hepatorenal Syndrome and Hepatic Encephalopathy
AKI in Cirrhosis
Start by reviewing haemodynamics and volume status, infection or bleeding, recent medication and fluid losses, urinalysis and the possibility of obstruction or intrinsic renal disease. Splanchnic vasodilatation and associated renal circulatory changes contribute to hepatorenal syndrome (HRS). Clinical causes can overlap.
Under the 2024 ADQI–ICA consensus, consider HRS-AKI in cirrhosis with ascites when there is AKI, no improvement in creatinine or urine output within 24 hours after adequate volume resuscitation when indicated, and no strong evidence of another primary cause. AKI criteria include a creatinine rise ≥26.5 micromol/L within 48 hours, a rise ≥50% from baseline within 7 days or urine output around or below 0.5 mL/kg/hour for at least 6 hours. Reassess after indicated fluids. The consensus advises against a routine 48-hour albumin course as a diagnostic prerequisite. HRS-AKI can coexist with chronic or structural kidney disease.
Confirmed HRS-AKI needs urgent specialist care. Terlipressin with concentrated IV albumin is a first-line regimen when appropriate. Tailor albumin to volume status and withhold it if overload develops. Check oxygenation and respiratory status, sepsis and contraindications. EMA warns of severe respiratory failure and sepsis and advises avoiding terlipressin in advanced renal dysfunction or advanced acute-on-chronic liver failure unless benefits outweigh risks. Noradrenaline in critical care is an alternative where appropriate. Renal support and transplant assessment depend on the whole clinical picture.
Overt Hepatic Encephalopathy in Cirrhosis
Portosystemic shunting and reduced hepatic clearance contribute to neuropsychiatric change. Look for altered behaviour, disorientation, asterixis, somnolence or coma. The diagnosis is clinical, with assessment for other causes of altered mental state. Check bedside glucose, infection, gastrointestinal bleeding, constipation, dehydration, kidney dysfunction, electrolyte disturbances and sedating medicines. An ammonia result alone does not establish the diagnosis. A normal result should prompt reconsideration.
Treat the trigger and protect the airway if consciousness is impaired. Use lactulose as first-line treatment where appropriate. Titrate ongoing dosing to around 2–3 soft stools daily, avoiding diarrhoea and dehydration. Rifaximin, usually 550 mg twice daily using the licensed Irish product, is an adjunct for appropriate recurrent overt encephalopathy. Support adequate nutrition and avoid routine protein restriction. Acute liver failure with encephalopathy requires its own critical care pathway.
ADQI–ICA AKI consensus · EMA terlipressin safety · EASL hepatic encephalopathy guidance
Adult Jaundice and Hepatitis
Look at bilirubin fractions and the relative rise of aminotransferases and cholestatic enzymes. A conjugated rise can occur in hepatocellular disease or cholestasis. Dark urine and pale stool support conjugated hyperbilirubinaemia with impaired bile flow. Patients can have mixed patterns. Red flags include worsening clotting, new encephalopathy, sepsis and progressive unexplained jaundice.
| Pattern | Reason through the next step |
|---|---|
| Isolated predominantly unconjugated bilirubin | Consider increased bilirubin production or impaired conjugation. Look for anaemia, increased reticulocytes and LDH and reduced haptoglobin when haemolysis is suspected. With a compatible history, otherwise reassuring tests and no evidence of haemolysis, consider Gilbert syndrome, which may become evident during fasting or illness. |
| Predominant aminotransferase rise | Review medications and exposures, circulatory shock and viral, immune or metabolic causes. Check INR and mental state promptly when acute severe injury is possible. |
| Predominant ALP rise of hepatic origin | Confirm hepatic origin with GGT when appropriate and obtain ultrasound to evaluate the liver and bile ducts. A normal-calibre duct does not exclude a stone or early obstruction. If suspicion persists, discuss MRCP or endoscopic ultrasound. In obstructive jaundice with suspected pancreatic or biliary cancer, arrange prompt specialist assessment and staging. |
Hepatitis Patterns
Acute hepatitis can be viral, autoimmune, drug-related, ischaemic or alcohol-related. Tailor testing to the presentation. For possible acute hepatitis A, use HAV IgM. In suspected acute hepatitis B, interpret HBsAg with anti-HBc IgM and the clinical context. Persistent HBsAg, HBV DNA and fibrosis or liver injury assessment guide chronic HBV referral and treatment decisions. HCV antibody identifies past exposure, while HCV RNA identifies active infection and can be helpful early after exposure. Link patients with confirmed active HCV to care for direct-acting antiviral treatment. Follow the applicable Irish public health guidance.
Alcohol-related hepatitis may cause new or worsening jaundice after sustained heavy alcohol use, with moderately elevated AST and usually an AST-to-ALT ratio above 1.5. Assess exposure, nutrition and competing causes including infection and obstruction. Provide support for abstinence, assess withdrawal risk and address nutrition. For severe alcohol-related hepatitis specialist care uses prognostic tools such as MELD and considers corticosteroids only after reviewing infection and other contraindications. Assess response with the Lille score if treatment is started.
Acute Cholangitis
Fever or inflammation plus cholestasis and biliary imaging evidence supports acute cholangitis. Fever, right upper quadrant pain and jaundice form Charcot's triad, but some patients lack one or more signs. Hypotension or altered mental state raises concern for organ dysfunction. Take cultures when feasible without delaying antibiotics. Treat promptly with IV antibiotics according to local policy and give reassessed IV crystalloid when hypoperfused. Involve endoscopy early to arrange drainage by severity. ESGE recommends drainage as soon as possible and within 12 hours in septic shock, and within 48–72 hours for moderate disease. ERCP can drain the duct and remove the stone or place a stent depending on stability and feasibility.
ESGE common bile duct stones guideline · Tokyo severity grading
Investigate possible hereditary haemochromatosis
Consider iron overload in a person with an affected parent or sibling, unexplained abnormal liver tests, or a combination such as fatigue, second or third metacarpophalangeal joint symptoms and diabetes. Unrecognised iron loading can cause fibrosis, cirrhosis, cardiomyopathy and endocrine disease. HFE C282Y homozygosity confers susceptibility, with variable clinical expression.
Measure transferrin saturation (TSAT) and ferritin together. Ferritin can rise with inflammation, alcohol-associated liver disease and metabolic dysfunction. A high ferritin with a single unremarkable TSAT result merits consideration of those alternatives and follow-up guided by the history. Persistent unexplained high TSAT, especially with high ferritin, supports genetic assessment in an appropriate patient. The HSE public threshold for suspected iron overload uses TSAT >45%. The European Association for the Study of the Liver (EASL) gives paired values of TSAT >45% and ferritin >200 µg/L in premenopausal women, and >50% and >300 µg/L in men and postmenopausal women. In an HFE C282Y homozygote, the paired European results support diagnosis without a separate demonstration of hepatic iron. In other genotypes with high indices, use specialist assessment for hepatic iron overload, usually MRI, and consider secondary causes. EASL finds no diagnostic advantage to fasting. Follow the receiving laboratory's sampling instructions where its protocol requests a fasting repeat.
Assess fibrosis and organ involvement at diagnosis. Ferritin around or above 1,000 µg/L or raised liver enzymes increases the need to clarify fibrosis, generally beginning with non-invasive assessment. Advanced fibrosis or cirrhosis requires specialist surveillance planning for hepatocellular carcinoma. Therapeutic venesection reduces iron stores when indicated. Follow ferritin and haemoglobin during induction and maintenance. Discuss testing with adult first-degree relatives, especially siblings.
HSE diagnosis · HSE venesection · EASL haemochromatosis guideline
Consider hepatitis D or E and act on paediatric deterioration
EASL recommends testing for anti-HDV at least once in a person with HBsAg positivity. Test for HDV RNA after a positive antibody result to determine whether there is active infection. Consider hepatitis E in otherwise unexplained acute hepatitis even without overseas travel. Discuss appropriate HEV serology and RNA testing with the laboratory, including in an immunocompromised patient. Follow the Irish HPSC HEV notification criteria. In a child with jaundice and abnormal liver tests, check age-specific alternatives and consider medicines, infection and the family and exposure history. New altered consciousness, hypoglycaemia or impaired coagulation requires urgent paediatric assessment with hepatology advice. A newborn with conjugated jaundice and pale stools has a separate time-critical assessment for cholestasis, even if feeding and growth appear normal.
EASL hepatitis delta guideline · Irish HPSC hepatitis E · Children’s Health Ireland paediatric hepatology · AASLD/AST/NASPGHAN paediatric liver transplantation guidance.
A 24-year-old woman is admitted to the intensive care unit 48 hours following an intentional overdose of paracetamol. Despite completing an intravenous N-acetylcysteine protocol and receiving appropriate resuscitation, her clinical condition deteriorates. She is obtunded, disoriented to time and place, and demonstrates marked asterixis (Grade 3 encephalopathy). Repeat laboratory investigations demonstrate: arterial blood pH 7.34 (on room air post-resuscitation), serum creatinine 340 mcmol/L, International Normalized Ratio (INR) 7.2, total bilirubin 142 mcmol/L, and arterial blood lactate 2.4 mmol/L. What is the most appropriate next step for this patient?
Administer intravenous vitamin K and defer liver-centre discussion pending another INR result
Contact the National Liver Transplant Unit immediately for urgent transplant assessment while continuing intensive care
Treat with renal replacement alone and reconsider liver referral when creatinine normalises
Administer intravenous flumazenil to reverse suspected benzodiazepine co-ingestion and repeat liver enzymes in 24 hours
A 54-year-old man with decompensated alcohol-related cirrhosis is admitted to the hospital with increasing abdominal distension and mild confusion. On examination, he is afebrile with shifting dullness and mild generalized abdominal discomfort without guarding. Asterixis is absent. An urgent diagnostic paracentesis is performed, yielding clear yellowish fluid. Ascitic fluid analysis reveals: total white cell count 620 cells/mcL with 65% polymorphonuclear neutrophils, total protein 14 g/L, and albumin 8 g/L. Paired serum albumin is 24 g/L and serum creatinine has risen from 78 to 124 micromol/L. Blood cultures are collected and ascitic fluid is inoculated into blood culture bottles at the bedside. What is the most likely diagnosis and the most appropriate initial treatment?
Peritoneal carcinomatosis; initiate intravenous dexamethasone and refer to palliative oncology
Secondary bacterial peritonitis; request emergency surgical laparotomy for suspected bowel perforation
Uncomplicated cirrhotic ascites; initiate oral spironolactone 100 mg daily and oral furosemide 40 mg daily
Spontaneous bacterial peritonitis. Start empirical IV antibiotics according to local guidance and give IV albumin for the rising creatinine unless contraindicated.
A 68-year-old woman is brought to the emergency department by her family with a 24-hour history of high fevers, shivering rigors, and right upper quadrant abdominal pain. Her daughter noticed that her eyes have turned noticeably yellow today. On examination, she is febrile at 39.1°C, heart rate is 112 bpm, blood pressure is 108/65 mmHg, and respiratory rate is 22 breaths/min. She is alert without evidence of organ failure and is visibly jaundiced with scleral icterus and has marked right upper quadrant tenderness on palpation. Urgent laboratory investigations show: total bilirubin 118 mcmol/L, conjugated bilirubin 92 mcmol/L, alkaline phosphatase (ALP) 580 U/L (reference: 30 - 130 U/L), alanine aminotransferase (ALT) 145 U/L (reference: < 45 U/L), and white cell count 18.2 x 10^9/L. An urgent abdominal ultrasound demonstrates a dilated common bile duct measuring 12 mm with acoustic shadowing stones in the distal duct and gallbladder cholelithiasis. What is the most appropriate next step in management?
Start IV antibiotics and supportive care, and contact endoscopy now to arrange early biliary drainage
Perform immediate emergency laparoscopic cholecystectomy within 6 hours of presentation
Prescribe oral ursodeoxycholic acid 500 mg twice daily and schedule elective outpatient magnetic resonance cholangiopancreatography (MRCP)
Administer high-dose intravenous methylprednisolone for acute autoimmune cholangitis and monitor transaminases
A 52-year-old man with a brother treated for haemochromatosis has second and third metacarpophalangeal joint pain. Repeated transferrin saturation is 66%, ferritin is 660 µg/L and there is no transfusion history. What is the best next diagnostic step?
Begin hepatocellular carcinoma surveillance without assessing fibrosis
Schedule therapeutic venesection solely on the ferritin value
Discuss HFE testing and assess possible hepatic and extrahepatic iron involvement
Attribute the ferritin result to joint inflammation and arrange no further assessment
A person with cirrhosis and ascites has increasing scale weight, early satiety, poor intake and loss of limb muscle. They are alert and stable. What is the best first plan for the nutrition concern?
Assume the higher weight excludes malnutrition
Give a low-protein diet to prevent all future encephalopathy
Assess dry-weight history, intake and muscle loss, involve a dietitian and plan achievable meals and supplementation as needed
Defer nutrition review until all ascites has resolved
A patient with chronic hepatitis B has a positive anti-HDV result at a routine review. Which test establishes whether hepatitis D is currently active?
Anti-HBs titre
A repeat test for hepatitis C antibody
Repeat bilirubin alone
HDV RNA testing
Sections you finish are checked off in the contents.